Rapid Nucleic Acid Reaction Circuits for Point-of-care Diagnosis of Diseases

Abstract

An urgent need exists for a rapid, cost-effective, facile, and reliable nucleic acid assay for mass screening to control and prevent the spread of emerging pandemic diseases. This urgent need is not fully met by current diagnostic tools. In this review, we summarize the current state-of-the-art research in novel nucleic acid amplification and detection that could be applied to point-of-care (POC) diagnosis and mass screening of diseases. The critical technological breakthroughs will be discussed for their advantages and disadvantages. Finally, we will discuss the future challenges of developing nucleic acid-based POC diagnosis.

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2022
Source ID
10.2174/1570163819666220207114148

Entities

People

  • Anthony Monte Carlo
  • Catherine Grgicak
  • Doris Zheng
  • Emily Guan
  • Ezry Santiago-McRae
  • Jinglin Fu
  • Omri Bar
  • Sung Won Oh

Organizations

  • High Technology High School
  • Rutgers University
  • Rutgers University–Camden
  • United States Department of Defense

Tags

Fields of Study

  • Chemistry
  • Medicine

Readers

  • Nanoscale Plasmonic Nanotechnology
  • Oncology (Cancer Research).
  • Strategic Security Studies

Technology Areas

  • Biotechnology